In HCC, TGF-β-induced METTL3-mediated m6A modification destabilizes ITIH1 mRNA, disrupting fibronectin and focal adhesion kinase signaling, thus driving tumor growth and invasion (66). The gene discussed is METTL3; the disease is hepatocellular carcinoma.